Patents and other proprietary rights are critical to our business at TheraPYX. We aggressively file new patent applications to protect our technology, inventions, and improvements. We have exclusive worldwide licenses from Brown University for a proprietary protein micronization and encapsulation process. Based on this method we have developed a unique second-generation platform technology, EXStaM (patent pending) that allows commercial scale microencapsulation of therapeutic proteins. Several of our methods and selection patents that protect specific products in specific indications have either been licensed, awarded, or are currently pending – including the applications covering our general scale-up methods that allow the consistent production of large batches of commercial-grade drug product.